A 52-year-old man with type 2 diabetes mellitus for 8 years presents with blurred vision. On examination, he has hard exudates arranged in a circinate pattern around the macula, with microaneurysms and dot-blot hemorrhages on fundoscopy. Visual acuity is 6/9 in both eyes. Which investigation is most appropriate to assess the extent of retinal involvement and guide treatment decisions?

Explanation

## Investigation of Choice in Diabetic Retinopathy Assessment ### Clinical Context The patient presents with signs of **nonproliferative diabetic retinopathy (NPDR)** with **diabetic macular edema (DME)** — evidenced by hard exudates in a circinate pattern around the macula. The goal is to: 1. Confirm the diagnosis 2. Assess the extent of retinal ischemia and vascular leakage 3. Determine if proliferative disease is present 4. Guide treatment (laser, anti-VEGF, or observation) ### Why Fundus Fluorescein Angiography (FFA) is Gold Standard **Key Point:** FFA is the gold standard investigation for diabetic retinopathy because it: - Detects **microaneurysms** (earliest sign of DR) - Identifies **areas of capillary nonperfusion** (ischemia) - Demonstrates **vascular leakage** (source of macular edema) - Reveals **neovascularization** (proliferative disease) - Provides **retinal perfusion map** to guide focal/panretinal photocoagulation **High-Yield:** FFA is essential for: - Classifying DR severity (mild, moderate, severe NPDR vs PDR) - Identifying **clinically significant macular edema (CSME)** — defined by FFA leakage within 500 µm of the fovea - Detecting **cotton-wool spots** and **intraretinal microvascular abnormalities (IRMA)** ### Comparison with Other Investigations | Investigation | Strength | Limitation | Role in DR | |---|---|---|---| | **FFA** | Detects ischemia, leakage, NV; gold standard | Dye allergy risk, time-consuming | **Diagnostic & treatment planning** | | **OCT (macular)** | High-resolution structural imaging; measures edema thickness | Does not show perfusion or ischemia | Quantifies DME severity; monitors treatment response | | **OCTA** | Non-invasive perfusion imaging; detects ischemic areas | Limited field; poor visualization of peripheral NV | Emerging tool; not yet standard for treatment decisions | | **B-scan** | Penetrates media opacities | No retinal detail; no perfusion data | Only if media too opaque for other imaging | **Clinical Pearl:** In this patient with clear media and NPDR with DME, FFA is mandatory before considering laser photocoagulation. It defines the exact location and extent of leakage (CSME criteria) and identifies ischemic zones that may progress to neovascularization. ### Mnemonic for DR Investigation Hierarchy **"FAD-OCTA"** - **F**undus examination (clinical diagnosis) - **A**ngiography (FFA — extent & ischemia) - **D**ilated fundus exam (confirm findings) - **O**CT (quantify edema, monitor therapy) - **C**TA (emerging; not yet standard) [cite:Harrison 21e Ch 424]